Posts Tagged “Results”
Kraton Polymers Announces Exceptional Performance Results In Houston, TX /PRNewswire/ – Kraton Performance Polymers, Inc. (NYSE: "KRA"), a leading global producer of styrenic block copolymers or "SBCs," tested performance properties of an industrial coatings starting point formulation made with Kraton™ FG1901 … Read more on Surface Finishing.com PolyOne Corporation – Value PolyOne manufactures specialized polymer materials which are found in just about every industry from transportation, to colors used in packaging, to electronics and healthcare. It provides services in natural rubber latex compounds, color additives, … Read more on NASDAQ DuPont at…. Click Here to Read More
No Comments »
Albemarle's CEO Discusses Q4 2011 Results – Earnings Call Transcript For the full year excellent pricing, reasonably strong demands through three fourths of the year and structural initiatives allowed Polymers to deliver full year net sales in excess of $ 1 billion for the first time, up 11% year-over-year; … Read more on Seeking Alpha European Coronary Stent Market to Decline to 0 Million by 2016, Despite … In biodegradable polymer stents, a polymer controls drug release but then disappears, leaving a bare metal stent. Examples of stents with biodegradable polymers are Biosensors International's BioMatrix, Terumo Medical's Nobori, Sahajanand Medical … Read…. Click Here to Read More
No Comments »
Posted by admin in Polymer News, tags: Announces, Call, Conference, Date, Flamel, Projected, Quarter, Release, Results, Second, Technologies
Flamel Technologies Announces Projected Release Date of Second Quarter Results; Conference Call LYON, FRANCE–(Marketwire – Jul 18, 2011) – Flamel Technologies ( NASDAQ : FLML ) expects to release its financial results for the second quarter of 2011 on Monday, July 25 th , after the market close. A conference call to discuss the results has been scheduled for Tuesday, July 26 th , at 8:30 AM (EDT). A question and answer period is expected to follow the discussion of results. Read more on Marketwire AdvanSource Biomaterials Completes 0K Debt Financing WILMINGTON, Mass.–(BUSINESS WIRE)–AdvanSource Biomaterials Corporation (OTC Markets OTCQB: ASNB), … Read more on citybizlist…. Click Here to Read More
No Comments »
Posted by admin in Polymer News, tags: 2011, Celanese, Corporation, First, outlook, Quarter, Raises, Remainder, Reports, Results, Year
Celanese Corporation Reports First Quarter 2011 Results; Raises Outlook for Remainder of Year DALLAS–(BUSINESSWIRE)– Celanese Corporation : Three Months Ended March 31, (in $ millions, except per share data) – Unaudited 2011 2010 As Adjusted3 Net sales 1,589 1,388 Operating … Read more on Business Wire Finance Press Releases UK via Yahoo! UK & Ireland…. Click Here to Read More
No Comments »
Silence Therapeutics – PF-04523655 Phase 2 Study Results Silence Therapeutics – PF-04523655 Phase 2 Study Results Read more on AFX CNF Finance Regulatory News via Yahoo! UK & Ireland…. Click Here to Read More
No Comments »
LyondellBasell Reports Fourth-Quarter and Full Year 2010 Results – Read more on PR Newswire via Yahoo!…. Click Here to Read More
No Comments »
AdvanSource Biomaterials Announces Fiscal 2011 Second Quarter Results WILMINGTON, Mass.–(BUSINESS WIRE)–AdvanSource Biomaterials Corporation (NYSE Amex: ASB), a leading developer of advanced polymer materials for a broad range of medical devices, today announced financial results for its fiscal 2011 second quarter ended September 30, 2010. Total revenues for the three months ended September 30, 2010 were $491,000 as compared with $518,000 for the comparable … Read more on Business…. Click Here to Read More
No Comments »
Dow Reports Third Quarter Results MIDLAND, Mich.–(BUSINESS WIRE)–The Dow Chemical Company (NYSE: DOW): Third Quarter 2010 Highlights Dow reported earnings of $0.45 per share. The Company delivered earnings of $0.54 per share excluding certain items,(3) compared with earnings of $0.24 per share in the year-ago period excluding certain items and discontinued operations. EBITDA(2) rose more than $350 million to more than $1.9 … Read more on Business…. Click Here to Read More
No Comments »
Posted by admin in Polymer News, tags: clinical, from, Heptagonist, LMWH, Phase, PMX60056, PolyMedix, Recent, Results, Reversal, Review, study
PolyMedix to Review Results from Recent Phase 1B LMWH Reversal Clinical Study with Heptagonist PMX-60056 RADNOR, Pa.—-PolyMedix, Inc. , an emerging bio-technology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has scheduled a webcast for Wednesday, June 9 at 4:00 PM Eastern Time. Read more on Business Wire via Yahoo!…. Click Here to Read More
No Comments »
Posted by admin in Polymer News, tags: Announces, Corporation, efficacy, Elixir, EXCELLA, Excellent, from, Medical, Month, Nine, Randomized, Results, Safety
Elixir Medical Corporation Announces Excellent Nine Month Safety And Efficacy Results From The EXCELLA II Randomized … Elixir Medical Corporation, a developer of product platforms combining state-of-the-art medical devices with advanced pharmaceuticals, announced today the superiority of the Elixir DESyne stent compared to the control Endeavor stent in the primary endpoint of the EXCELLA II randomized clinical trial. The Elixir DESyne Stent is the first drug eluting stent with the thinnest durable polymer … Read more on Medical News…. Click Here to Read More
No Comments »
FSI Announces First Quarter, 2010 Financial Results VICTORIA, British Columbia—-FLEXIBLE SOLUTIONS INTERNATIONAL, INC. , is the developer and manufacturer of biodegradable polymers for oil extraction, detergent ingredients and crop nutrient availability chemistry, as well as biodegradable and environmentally safe water and energy conservation technologies. Read more on Business Wire via Yahoo!…. Click Here to Read More
No Comments »
Allianz SE posts financial results beats estimates Allianz SE posts financial results beats estimates Read more on…. Click Here to Read More
No Comments »
|